DanCann Pharma A/S: Carsten Trads, Chairman, comments on the Rights Issue
COPENHAGEN, Denmark, September 5, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma", “DCP” or the “Company”), a Danish company powered by cannabinoids, hereby comments on the Rights Issue communicated last week on behalf of the Chairman of the Company, Carsten Trads.Carsten Trads, Chairman, comments: Dear DanCann Pharma shareholders, DanCann Pharma is on a growth journey towards the commercialization of the sale of medicinal cannabis from the company's production facility, Biotech Pharm1. It requires equity and liquidity. We have been lucky and skilled in getting capital from 4,